IDesia Ltd., an Israeli Biometrics Technology Company was founded in 2004 to develop and market BDS™ (BioDynamic Signature™), the company’s state-of-the-art technology enabling a broad range of Biometrics-based, user identity-aware applications. IDesia’s patented BDS™ Technology (PATENT NUMBER 7689833 & 7171681) has been thoroughly tested by the UK-based National Physical Laboratory (NPL). IDesia provides BioDynamic Signature (BDS™), a personal biometric authentication technology that captures “Electro Physiological Signal unique to each individual.” The company also provides application kits, BDS Sensor and BDS ProSensor chipsets, smart cards and fusion products to Original Equipment Manufacturer (OEM) of personal portable electronic devices, as well as to vendors and system integrators working in the Homeland Security Areas. In addition, it offers development and co-development services. IDesia’s current application offerings are focused on Biometric Authentication, Personal Health, Fitness and Well-being. IDesia’s solutions present greater value, reliability, ease-of-use making it easy for high user compliance and supporting powerful personalization options. IDesia was formerly known as C-Signature Ltd. The Company is based in Caesarea, Israel. As of July 2, 2012, IDesia Ltd. Operates as a subsidiary of Intel Corporation.